Maxton et al v. Prinston Pharmaceutical Inc. et al
| Lisa Maxton and Jon Maxton |
| PRINSTON PHARMACEUTICAL INC. d/b/a Solco Healthcare LLC and SOLCO HEALTHCARE U.S. LLC |
| VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
| 1:2020cv12395 |
| September 8, 2020 |
| US District Court for the District of New Jersey |
| Robert B Kugler |
| Joel Schneider |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 16, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Notice to MICHAEL P. MURPHY re mandatory eFiling. (dmr) |
| Filing 10 Certified Copy of Transfer Order and docket received, Case transferred in from District of Illinois Southern; Case Number 3:20-cv-00793. Original file certified copy of transfer order and docket sheet received. |
| Judge Robert B. Kugler and Magistrate Judge Joel Schneider added. (dd, ) |
| Case Transferred per CTO-31 on 9/8/20 from Illinois Southern (dd, ) |
| Filing 9 CONDITIONAL TRANSFER ORDER (CTO-31) TRANSFERRING CASE TO OTHER DISTRICT: Case transferred to District of New Jersey and MDL No. 2875 In Re: Valsartan, Losartan, and Irbesartan Products Liability Litigation. (kek) |
| Filing 8 PRELIMINARY CONDITIONAL TRANSFER ORDER (CTO-31) as assigned by Judicial Panel on Multidistrict Litigation. (rah) |
Filing 7
ORDER granting #6 Motion for Extension of Time to Answer. The Court ALLOWS Defendants up to and including September 14, 2020 to respond or answer to the complaint. Signed by Magistrate Judge Gilbert C. Sison on 8/31/2020. (klh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED.
|
| Filing 6 MOTION for Extension of Time to File Answer DEFENDANTS MOTION FOR EXTENSION OF TIME TO ANSWER OR OTHERWISE PLEAD by Prinston Pharmaceutical Inc., Solco Healthcare U.S., LLC. (St. Aubin, Keith) |
| Filing 5 NOTICE REGARDING FILING re #1 Notice of Removal filed by Solco Healthcare U.S., LLC, Prinston Pharmaceutical Inc. and #2 Notice of Appearance filed by Solco Healthcare U.S., LLC, Prinston Pharmaceutical Inc. The Civil Cover Sheet attached at Doc #1 and the Notice of Appearance attached at Doc. #3 are fillable documents. Fillable documents should be converted to non-fillable PDF documents before filing on CM/ECF. This Notice is sent for informational purposes only. No further action required. (kls3)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
| Filing 4 NOTICE OF INITIAL ASSIGNMENT TO A U.S. MAGISTRATE JUDGE: This case has been randomly assigned to United States Magistrate Judge Gilbert C. Sison pursuant to Administrative Order No. 257. The parties are advised that their consent is required if the assigned Magistrate Judge is to conduct all further proceedings in the case, including trial and final entry of judgment pursuant to 28 U.S.C. 636(c) and Federal Rule of Civil Procedure 73. As set forth in Administrative Order No. 257, each party will be required to file a Notice and Consent to Proceed Before a Magistrate Judge Jurisdiction form indicating consent or nonconsent to the jurisdiction of the assigned Magistrate Judge. If all parties do not consent to the Magistrate Judge's jurisdiction, the case will be randomly assigned to a district judge for all further proceedings and the parties cannot later consent to reassignment of the case to a magistrate judge. The parties are further advised that they are free to withhold consent without adverse substantive consequences. Within 21 days of this Notice, the following party or parties must file the attached form indicating consent to proceed before the assigned Magistrate Judge or an affirmative declination to consent: Jon Maxton, Lisa Maxton, Prinston Pharmaceutical Inc., Solco Healthcare U.S., LLC. A link regarding the magistrate judges in this district is attached for your convenience: #http://www.ilsd.uscourts.gov/documents/BenefitsofConsent.pdf. All future documents must bear case number 3:20-cv-793-GCS. Refer to Civil/Removal Case Processing Requirements, found on the ILSD website, for further service information. Consent due by 9/8/2020 (kls3)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. (kls3). |
| Filing 3 Corporate Disclosure Statement by All Defendants identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd, Other Affiliate Solco Healthcare US, LLC for Prinston Pharmaceutical Inc.. (St. Aubin, Keith) |
| Filing 2 NOTICE of Appearance by Keith M. St. Aubin on behalf of All Defendants (St. Aubin, Keith) |
| Filing 1 NOTICE OF REMOVAL from Circuit Court of St. Clair County, case number 20 L 530 ( Filing fee $ 400 receipt number 0754-4256373), filed by All Defendants. (Attachments: #1 Exhibit A-D)(St. Aubin, Keith) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
